NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Health Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



3M



3M Health Care and Greystone Pharmaceuticals, Inc. Announce License Agreement for Innovative Wound Care Technology



August 8th, 2008

3M Health Care and Greystone Pharmaceuticals, Inc. announce they have entered into an exclusive, worldwide license agreement for wound care products using Greystone's patented PHI technology, a proprietary formulation that aids in the management of hard-to-heal wounds.

This is the second agreement between 3M Health Care and Greystone Pharmaceuticals, Inc. The first agreement provided 3M Health Care limited distribution rights in Canada and parts of Europe. This new agreement broadens 3M Health Care's rights to the United States and most major countries in the world, starting with the introduction of 3M(TM) Tegaderm(TM) Matrix Dressing with PHI technology to the U.S....


Source: Health Business Week (2008-08-08)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login